Renal cell carcinoma with central nervous system demyelination caused by nivolumab

INTRODUCTION: Central nervous system demyelination caused by immune checkpoint inhibitors is a very rare condition. CASE PRESENTATION: A 65‐year‐old man who received nivolumab for renal cell carcinoma developed abnormal behavior, such as disagreeable speech and sudden anger. Brain‐enhanced magnetic...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:IJU Case Rep
Glavni autori: Oka, Toshiki, Yamamoto, Yoshiyuki, Okuda, Yohei, Asakura, Toshihisa, Hatano, Koji, Nakai, Yasutomo, Nakayama, Masashi, Kakimoto, Ken‐ichi, Sugai, Fuminobu, Nishimura, Kazuo
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Case Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7784733/
https://ncbi.nlm.nih.gov/pubmed/33426497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iju5.12234
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items